Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of the Medicines Optimisation Assessment Tool (MOAT) - Targeting Hospital Pharmacists' Input to Reduce Risks and Improve Patient Outcomes

NCT02582463 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT02582463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02582463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of the Medicines Optimisation Assessment Tool (MOAT) - Targeting Hospital Pharmacists' Input to Reduce Risks and Improve Patient Outcomes
Lead sponsor
University College, London
Phase
Observational
Overall status
Completed
Start date
April 30, 2016
Completion date
March 2, 2018
Enrollment
1,552 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

medicines optimisation